Financials
- Market Capitalization 271.99 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-3.82
売上高対価格比率
43.33
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3391 | TTRX Turn Therapeutics Inc. - Common Stock | 9.60 USD | -0.41% | -14.44% | +47.24% | -4.00% | 285.97 M USD | ||
| 3403 | GLSI Greenwich LifeSciences, Inc. - Common stock | 19.30 USD | +1.53% | +6.51% | -16.23% | +90.52% | 283.29 M USD | ||
| 3422 | NAGE Niagen Bioscience, Inc. - Common Stock | 3.40 USD | +3.34% | -2.02% | -3.41% | -31.73% | 270.79 M USD | ||
| 3423 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.66 USD | +1.67% | -2.92% | -6.15% | +30.71% | 279.86 M USD |